Therapeutic Asset Ratings
154 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Calcium folinate pentahydrate
Cervical Cancer
Neonc Technologies, Inc.
P1/2
CC
(46)
FULVESTRANT
Cervical Cancer
Terremoto Biosciences Inc.
P1/2
CC
(46)
Polyiclc
Cervical Cancer
Mayo Clinic
P1/2
CC
(45)
gsk2110183
Cervical Cancer
Laekna Limited
P1/2
CC
(44)
n-803
Cervical Cancer
ImmunityBio, Inc.
P2
CC
(42)
177lu-betabart
Cervical Cancer
Radiopharm Theranostics, Ltd
P1/2
CC
(41)
Alpha Tocopherol
Cervical Cancer
University of Nebraska
P1/2
CC
(41)
Amxt1501
Cervical Cancer
Aminex Therapeutics, Inc.
P1/2
CC
(41)
azd5305
Cervical Cancer
AstraZeneca
P1/2
CC
(41)
Bms-936558-01
Cervical Cancer
Bristol-Myers Squibb
P1/2
CC
(41)
Camizestrant
Cervical Cancer
AstraZeneca
P1/2
CC
(41)
Carbon Nanoparticle-Loaded Iron
Cervical Cancer
Sichuan Enray Pharmaceutical Sciences Company
P1/2
CC
(41)
Cervical Cancer-Specific Car-T Cells
Cervical Cancer
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(41)
coq10
Cervical Cancer
University of Nebraska
P1/2
CC
(41)
Datopotamab Deruxtecan
Cervical Cancer
AstraZeneca
P1/2
CC
(41)
DEXAMETHASONE
Cervical Cancer
Seoul National University Hospital
P1/2
CC
(41)
Eflornithine
Cervical Cancer
Aminex Therapeutics, Inc.
P1/2
CC
(41)
Entinostat
Cervical Cancer
National Cancer Institute (NCI)
P1/2
CC
(41)
Enzalutamide
Cervical Cancer
Cancer Research UK
P1/2
CC
(41)
Epinephrine
Cervical Cancer
National Cancer Institute (NCI)
P1/2
CC
(41)
Gamma1 heavy chain humanized (1-450) [VH (Homo sapiens IGHV4-31*01 (89.9%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT [9.7.13] (26-34.52-58.97-109)) (1-120) -Homo sapiens IGHG1*01 (100%), G1m17,1 CH1 K120, D12, L14 (CH1 K120 (217) (121-218), hinge 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)], (223-214')-disulfide with kappa light chain humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-12*01 (85.3%)-IGKJ2*01 (100%), CDR-IMGT [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; dimer (229-229'':232-232'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, derived from the cell line CHO-K1,glycoform alfa
Cervical Cancer
Cancer Research UK
P1/2
CC
(41)
gi-101a
Cervical Cancer
GI Innovation, Inc.
P1/2
CC
(41)
gm103
Cervical Cancer
GeneMedicine Co., Ltd.
P1/2
CC
(41)
Gotistobart
Cervical Cancer
OncoC4, Inc.
P1/2
CC
(41)
hb0028
Cervical Cancer
Shanghai Huaota Biopharmaceutical Co., Ltd.
P1/2
CC
(41)
Showing 51 to 75 of 154 assets
Previous
Page 3 of 7
Next
